Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.
The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.
Chief Medical Officer, Professor Chris Whitty has announced that two cases of coronavirus have been confirmed in England.
The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
Dr Tejas Patel, a world-renowned interventional cardiologist and endovascular therapist, highlights cardiovascular disease, a leading cause of disability and premature death around the world.
Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.
Here we find out how The Japanese Society of Nephrology engages in research developing human resources, providing lifelong education and disseminating knowledge to the public, to tackle kidney disease and promote health.
Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.
Professor Yoshiaki Hasegawa discusses the structure and biogenesis mechanism of Mfa1 fimbriae from the periodontal pathogen Porphyromonas gingivalis.
Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED) details the challenges around global data sharing for orphan diseases.
In this interview, Chair of the ESC Digital Health Committee, Professor Martin Cowie, details the opportunities and challenges in the digital health era when it comes to the field of cardiovascular disease.
Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.